论文部分内容阅读
目的探讨糖尿病性白内障患者超声乳化联合人工晶体植入术的安全性及临床效果。方法 73例(76眼)糖尿病性白内障,于角膜缘后1 mm处作长3 mm的巩膜隧道切1∶2,行白内障超声乳化联合人工晶体植入术。术后随访观察1~3个月。结果所有病例均顺利完成手术,人工晶体I期植入囊袋内。术后视力:0.01~0.1者5眼(6.8%),0.2~0.4者21眼(28.76%),0.5~1.0者53眼(73%)。术后1 d视力提高≥0.5~1.0者52例(71.2%),术后1周时66例(90%),并趋于稳定。主要并发症包括不同程度的葡萄膜灸反应,其中11眼出现人工晶体前膜(8%);角膜水肿8眼(6%),后囊膜混浊15眼(21%)。结论糖尿病性白内障行超声乳化联合人工晶体植入术是安全的、有效的,并可获得良好的临床效果。
Objective To investigate the safety and clinical effect of phacoemulsification and intraocular lens implantation in patients with diabetic cataract. Methods 73 eyes (76 eyes) with diabetic cataract were scleral tunnel 1 mm long and 3 mm long after 1 mm posterior limbal cataract. Phacoemulsification and intraocular lens implantation were performed. Postoperative follow-up observation of 1 to 3 months. Results All cases were successfully completed surgery, I intraocular lens implantation within the capsular bag. Postoperative visual acuity: 5 eyes (6.8%) were 0.01-0.1, 21 eyes (28.76%) were 0.2-0.4, and 53 eyes (73%) were 0.5-1.0. 52 cases (71.2%) had visual acuity ≥0.5 ~ 1.0 one day after operation, 66 cases (90%) one week after operation and tended to be stable. The major complications included varying degrees of uveal moxibustion, including 11 eyes of anterior lens (8%), 8 eyes (6%) of corneal edema and 15 eyes (21%) of posterior capsule opacity. Conclusion Phacoemulsification combined with intraocular lens implantation in diabetic cataract is safe and effective, and can achieve good clinical results.